About Amedica Corporation (NASDAQ:AMDA)
Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Devices & Implants
- Sub-Industry: N/A
- Symbol: NASDAQ:AMDA
- CUSIP: N/A
- Web: www.amedica.com
- Market Cap: $13.05 million
- Outstanding Shares: 36,264,000
- 50 Day Moving Avg: $0.31
- 200 Day Moving Avg: $0.35
- 52 Week Range: $0.26 - $1.09
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.20
- P/E Growth: 0.0000
- Annual Revenue: $15.23 million
- Price / Sales: 0.86
- Book Value: $0.53 per share
- Price / Book: 0.69
- Average Volume: 283,763 shs.
- Beta: -2.16
- Short Ratio: 7.39
Frequently Asked Questions for Amedica Corporation (NASDAQ:AMDA)
What is Amedica Corporation's stock symbol?
Amedica Corporation trades on the NASDAQ under the ticker symbol "AMDA."
How were Amedica Corporation's earnings last quarter?
Amedica Corporation (NASDAQ:AMDA) issued its quarterly earnings data on Thursday, August, 11th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.09. The company earned $4 million during the quarter, compared to analysts' expectations of $4.20 million. View Amedica Corporation's Earnings History.
When will Amedica Corporation make its next earnings announcement?
Where is Amedica Corporation's stock going? Where will Amedica Corporation's stock price be in 2017?
1 brokerages have issued 1 year price targets for Amedica Corporation's stock. Their forecasts range from $5.00 to $5.00. On average, they expect Amedica Corporation's share price to reach $5.00 in the next twelve months. View Analyst Ratings for Amedica Corporation.
Who are some of Amedica Corporation's key competitors?
Some companies that are related to Amedica Corporation include HTG Molecular Diagnostics (HTGM), Pain Therapeutics (PTIE), Kitov Pharmaceuticals Holdings (KTOV), Onconova Therapeutics (ONTX), Xenetic Biosciences (XBIO), Apricus Biosciences (APRI), Heat Biologics (HTBX), Cellectar Biosciences (CLRB), Capnia (SLNO), Catalyst Biosciences (CBIO), Repros Therapeutics (RPRX), Jaguar Animal Health (JAGX), Sonoma Pharmaceuticals (SNOA), Eleven Biotherapeutics (EBIO), Trimel Pharmaceuticals Corp. (TRLPF), OpGen (OPGN), Eyegate Pharmaceuticals (EYEG) and DelMar Pharmaceuticals (DMPI).
Who are Amedica Corporation's key executives?
Amedica Corporation's management team includes the folowing people:
- B. Sonny Bal M.D., Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
- Bryan J. McEntire, Chief Technology Officer
- Dana Lyons, Vice President - Sales and Marketing
- Eric A. Stookey, Independent Director
- David W. Truetzel CPA, Independent Director
- Jeffrey S. White, Independent Director
How do I buy Amedica Corporation stock?
Shares of Amedica Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Amedica Corporation's stock price today?
MarketBeat Community Rating for Amedica Corporation (NASDAQ AMDA)MarketBeat's community ratings are surveys of what our community members think about Amedica Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Amedica Corporation stock can currently be purchased for approximately $0.36.
Consensus Ratings for Amedica Corporation (NASDAQ:AMDA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Hold Rating|
|Consensus Rating:||Hold (Score: 2.00)|
|Consensus Price Target: ||$5.00 (1,289.66% upside)|Consensus Price Target History for Amedica Corporation (NASDAQ:AMDA)
Analysts' Ratings History for Amedica Corporation (NASDAQ:AMDA)
(Data available from 10/22/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/25/2017||Maxim Group||Downgrade||Buy -> Hold||Low|
|1/5/2016||Ladenburg Thalmann Financial Services||Initiated Coverage||Buy||$0.35||N/A|
|11/14/2015||Needham & Company LLC||Reiterated Rating||Buy||$1.00||N/A|
Earnings History for Amedica Corporation (NASDAQ:AMDA)Earnings History by Quarter for Amedica Corporation (NASDAQ AMDA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/9/2017|| || || || || || || || |
|11/10/2016||Q316||($0.20)||($0.30)||$4.11 million||$3.40 million||View||N/A|
|8/11/2016||Q216||($0.31)||($0.40)||$4.20 million||$4.00 million||View||Listen|
|5/12/2016||Q116||($0.25)||($0.30)||$4.98 million||$4.20 million||View||Listen|
|11/12/2015||Q315||($0.06)||($0.15)||$5.00 million||$4.80 million||View||N/A|
|11/6/2014||Q314||($0.51)||($0.39)||$5.95 million||$6.00 million||View||N/A|
|3/31/2014||Q413||($3.35)||$0.87||$5.45 million||$5.70 million||View||N/A|
Earnings Estimates for Amedica Corporation (NASDAQ:AMDA)
Current Year EPS Consensus Estimate: $-0.47 EPS
Next Year EPS Consensus Estimate: $-0.3 EPS
Dividend History for Amedica Corporation (NASDAQ:AMDA)
No dividend announcements for this company have been tracked by MarketBeat.com
Headline Trends for Amedica Corporation (NASDAQ:AMDA)
Latest Headlines for Amedica Corporation (NASDAQ:AMDA)
Loading headlines, please wait.
Amedica Corporation (AMDA) Chart for Sunday, October, 22, 2017